CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.

Biotechnology

CinCor Pharma

Marc De Garidel

Mason W. Freeman

Michael Kalb

William (Bill) Marshall

Kevin Schutz, PharmD

William Marshall

Kevin Schutz

Jack Greene

James Hui

Jane Chamberland

Jonathan Isaacsohn

The Clinical and Medical Team at CinCor Pharma is responsible for designing, overseeing, and interpreting clinical trials for CIN-107. They manage all aspects of clinical operations, pharmacology, and translational research to ensure efficacy and safety while advancing therapeutic options for hypertensive patients.

Clinical and Medical Team

Scientific Team

Leadership Team

Clinical and Medical Team

About

Team members

Other teams at CinCor Pharma

Scientific Team

Leadership Team